Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit

Chemoprevention of prostate cancer by second-generation selenium compounds in reference to selenomethionine holds strong promise to deal with the disease at the root. Here we used the transgenic adenocarcinoma mouse prostate (TRAMP) model to establish the efficacy of methylseleninic acid (MSeA) and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wang, Lei, Bonorden, Melissa J. L., Li, Guang-xun, Lee, Hyo-Jeong, Hu, Hongbo, Zhang, Yong, Liao, Joshua D., Cleary, Margot P., Lü, Junxuan
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2822708/
https://ncbi.nlm.nih.gov/pubmed/19401524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-08-0173
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi